Cargando…
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211079/ https://www.ncbi.nlm.nih.gov/pubmed/32241793 http://dx.doi.org/10.1136/annrheumdis-2020-217424 |
_version_ | 1783531388985671680 |
---|---|
author | Monti, Sara Balduzzi, Silvia Delvino, Paolo Bellis, Elisa Quadrelli, Verdiana Serena Montecucco, Carlomaurizio |
author_facet | Monti, Sara Balduzzi, Silvia Delvino, Paolo Bellis, Elisa Quadrelli, Verdiana Serena Montecucco, Carlomaurizio |
author_sort | Monti, Sara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7211079 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-72110792020-05-12 Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Monti, Sara Balduzzi, Silvia Delvino, Paolo Bellis, Elisa Quadrelli, Verdiana Serena Montecucco, Carlomaurizio Ann Rheum Dis Letter BMJ Publishing Group 2020-05 2020-04-02 /pmc/articles/PMC7211079/ /pubmed/32241793 http://dx.doi.org/10.1136/annrheumdis-2020-217424 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Letter Monti, Sara Balduzzi, Silvia Delvino, Paolo Bellis, Elisa Quadrelli, Verdiana Serena Montecucco, Carlomaurizio Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
title | Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
title_full | Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
title_fullStr | Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
title_full_unstemmed | Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
title_short | Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
title_sort | clinical course of covid-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211079/ https://www.ncbi.nlm.nih.gov/pubmed/32241793 http://dx.doi.org/10.1136/annrheumdis-2020-217424 |
work_keys_str_mv | AT montisara clinicalcourseofcovid19inaseriesofpatientswithchronicarthritistreatedwithimmunosuppressivetargetedtherapies AT balduzzisilvia clinicalcourseofcovid19inaseriesofpatientswithchronicarthritistreatedwithimmunosuppressivetargetedtherapies AT delvinopaolo clinicalcourseofcovid19inaseriesofpatientswithchronicarthritistreatedwithimmunosuppressivetargetedtherapies AT belliselisa clinicalcourseofcovid19inaseriesofpatientswithchronicarthritistreatedwithimmunosuppressivetargetedtherapies AT quadrelliverdianaserena clinicalcourseofcovid19inaseriesofpatientswithchronicarthritistreatedwithimmunosuppressivetargetedtherapies AT montecuccocarlomaurizio clinicalcourseofcovid19inaseriesofpatientswithchronicarthritistreatedwithimmunosuppressivetargetedtherapies |